139 related articles for article (PubMed ID: 15668264)
21. Life threatening lung toxicity induced by low doses of bleomycin in a patient with Hodgkin's disease.
Real E; Roca MJ; Viñuales A; Pastor E; Grau E
Haematologica; 1999 Jul; 84(7):667-8. PubMed ID: 10406918
[No Abstract] [Full Text] [Related]
22. Mees' lines because of chemotherapy for Hodgkin's lymphoma.
Piccolo V; Corneli P; Zalaudek I; Argenziano G; Conforti C; Alfano R; Russo T
Int J Dermatol; 2020 Feb; 59(2):e38. PubMed ID: 31566709
[No Abstract] [Full Text] [Related]
23. Pulmonary lymphocyte-rich classical Hodgkin lymphoma with early response to ABVD therapy.
Honda A; Nakamura F; Nannya Y; Shintani Y; Fukayama M; Ichikawa M; Kurokawa M
Ann Hematol; 2014 Jun; 93(6):1073-4. PubMed ID: 24173088
[No Abstract] [Full Text] [Related]
24. Hodgkin's disease in HIV-infected patients: report of eight cases usefully treated with doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) plus granulocyte colony- stimulating factor.
Gastaldi R; Martino P; Gentile G; Picardi V; De Propris MS; Pirillo MF; De Vellis A; Mandelli F
Ann Oncol; 2002 Jul; 13(7):1158-60. PubMed ID: 12176798
[No Abstract] [Full Text] [Related]
25. Primary cutaneous Hodgkin's lymphoma.
Mukesh M; Shuttleworth D; Murray P
Clin Exp Dermatol; 2009 Dec; 34(8):e673-5. PubMed ID: 19817768
[TBL] [Abstract][Full Text] [Related]
26. Unusual presentation of Hodgkin's lymphoma.
Knibbeler-van Rossum CT; Peters FJ; Erdkamp FL; Bos LP
Ann Oncol; 2002 Apr; 13(4):637-8. PubMed ID: 12056718
[No Abstract] [Full Text] [Related]
27. [Cardiogenic shock during polychemotherapy in a patient with Hodgkin's disease].
Drzewoski J; Chojnowski K; Olszańska-Skorek T; Krykowski E
Kardiol Pol; 1986; 29(8):555-9. PubMed ID: 2435945
[No Abstract] [Full Text] [Related]
28. Chemotherapy for Hodgkin's disease.
Ekert H
N Engl J Med; 2003 Sep; 349(12):1186-7; author reply 1186-7. PubMed ID: 13679536
[No Abstract] [Full Text] [Related]
29. Pericardial effusion due to pericardium involvement by Hodgkin's lymphoma.
Guastafierro S; Cappabianca S; Falcone U
Ann Hematol; 2013 Jun; 92(6):853-4. PubMed ID: 23196418
[No Abstract] [Full Text] [Related]
30. Hematuria--a rare presentation of Hodgkin lymphoma.
Dembla V; Walker BN; Elkins SL; Files JC
Clin Adv Hematol Oncol; 2011 Oct; 9(10):788-90; discussion 791-2. PubMed ID: 22252582
[No Abstract] [Full Text] [Related]
31. Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma.
Sun HL; Atenafu EG; Tsang R; Kukreti V; Marras TK; Crump M; Kuruvilla J
Leuk Lymphoma; 2017 Nov; 58(11):2607-2614. PubMed ID: 28504035
[TBL] [Abstract][Full Text] [Related]
32. MOPP, ABVD, or both to treat Hodgkin's disease.
Aisenberg AC
N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680765
[No Abstract] [Full Text] [Related]
33. Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity.
Jóna Á; Miltényi Z; Ujj Z; Garai I; Szilasi M; Illés Á
Expert Opin Drug Saf; 2014 Oct; 13(10):1291-7. PubMed ID: 25135756
[TBL] [Abstract][Full Text] [Related]
34. Unusual manifestation of Hodgkin disease.
Dunlap N; Parkhie S
Am J Clin Oncol; 2006 Oct; 29(5):529-30. PubMed ID: 17023792
[No Abstract] [Full Text] [Related]
35. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease.
Jost LM; Stahel RA;
Ann Oncol; 2005; 16 Suppl 1():i54-5. PubMed ID: 15888755
[No Abstract] [Full Text] [Related]
36. ABVD in the treatment of Hodgkin's disease.
Bonfante V; Santoro A; Viviani S; Valagussa P; Bonadonna G
Semin Oncol; 1992 Apr; 19(2 Suppl 5):38-44; discussion 44-5. PubMed ID: 1384143
[TBL] [Abstract][Full Text] [Related]
37. [Flagellate erythema].
Curi Tuma M; Sandoval Osses M; Salazar Gangas C
Med Clin (Barc); 2014 Sep; 143(6):e11. PubMed ID: 24952662
[No Abstract] [Full Text] [Related]
38. Uncommon presentations of Hodgkin's disease. Case 2. Hodgkin's disease of the nasopharynx.
Hollander SL
J Clin Oncol; 2004 Jan; 22(1):195-6. PubMed ID: 14701783
[No Abstract] [Full Text] [Related]
39. Classical Hodgkin's lymphoma associated with Langerhans cell histiocytosis: multiagent chemotherapy resulted in histologic resolution of both the classical Hodgkin's lymphoma and Langerhans cell proliferation components.
Greaves WO; Bueso-Ramos C; Fayad L
J Clin Oncol; 2011 Feb; 29(4):e76-8. PubMed ID: 21041711
[No Abstract] [Full Text] [Related]
40. Long-term follow up of patients with human immunodeficiency virus infection and advanced stage Hodgkin's lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine.
Xicoy B; Miralles P; Morgades M; Rubio R; Valencia ME; Ribera JM
Haematologica; 2013 Aug; 98(8):e85-6. PubMed ID: 23716563
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
